Exec Director, Global Commercial Product Strategy - Lenacapavir for Prevention
Scorpion Therapeutics, San Francisco, California, United States, 94199
Role Summary
The Executive Director, Global Commercial Product Strategy for Lenacapavir for Prevention is responsible for shaping and leading the global commercial vision, strategy, and execution for one of Gilead’s most important long-acting HIV prevention portfolios. This leader will oversee global commercial launch of lenacapavir for HIV prevention and guide early commercial planning for future lenacapavir prevention assets in the pipeline. The role drives cross-functional alignment, regional partnership, market development, and launch excellence to enable sustained global growth. This position requires a strategic, collaborative leader with deep global commercial expertise, strong cross-functional leadership capabilities, and a passion for advancing HIV prevention worldwide. Responsibilities
Lead a cross-geography commercialization strategy and execution team to define and deliver the global commercial vision, long-range strategy, and integrated annual plans for the lenacapavir prevention portfolio. Serve as Commercialization Team Leader, enabling decision making across Medical Affairs, Clinical Development, Value & Access, Public Affairs, Government Affairs, Regulatory, Legal, and Insights partners. Lead the development of the Indication Strategic Plan (ISP) and Global Plan of Action (GPOA), ensuring clear linkage to regional and country HIV prevention plans. Lead, coach, and develop a high performing global team, fostering a culture of inclusion, accountability, collaboration, and innovation. Manage and shape external partnerships, agency relationships, and global marketing investments. Build strong and trusted partnerships with Gilead’s priority (G9) and emerging markets to ensure global strategies are actionable, scalable, and tailored to local needs. Collaborate closely with Value & Access to shape pricing, access, and reimbursement strategies across diverse healthcare, prevention, and policy environments. Support global guidelines, policy, and ecosystem shaping efforts to expand access to long-acting HIV prevention. Integrate global market intelligence, competitive insights, and customer needs into commercial, clinical, access, and evidence generation strategies. Identify and translate market, customer, and ecosystem insights into clear business opportunities, strategic priorities, and global commercial plans. Lead global launch readiness and market preparation for the ex-US rollout of lenacapavir for Prevention, ensuring coordinated preparation across regions. Oversee early commercial planning and readiness activities for future lenacapavir prevention assets as they advance through development. Drive global brand positioning, messaging, and multichannel campaign development to ensure clear differentiation and strong early market establishment. Provide commercial leadership into clinical development, lifecycle planning, evidence generation, and publication strategy to support future label, payer, and customer needs. Contribute to long-range planning, scenario planning, asset valuation, and enterprise strategy discussions. Develop executive level materials for Earnings Calls, LE guidance, long-range plan (LRP), governance forums, and strategic reviews. Represent Global Commercial Strategy in enterprise initiatives related to HIV, prevention, long-acting platforms, and access expansion. Qualifications
Required: 15+ years of biopharmaceutical commercial experience, including extensive global or regional strategy leadership. Required: Proven experience leading cross functional teams and influencing senior executive levels. Required: Experience working within or across multiple key markets. Required: Demonstrated success in global launch planning, market development, or brand strategy for specialty or prevention focused therapeutics. Required: Strong strategic thinking, analytical skills, and ability to translate insights into actionable strategies. Required: Excellent leadership, communication, and stakeholder management capabilities. Preferred: HIV, infectious disease, or prevention ecosystem experience. Preferred: Consumer/Direct to Consumer experience. Preferred: Prior responsibility for evidence strategy, lifecycle planning, or shaping policy/market access environments. Skills
Strategic agility and enterprise mindset Cross functional influence and decision leadership Customer, market, and policy insight orientation Inclusive people leadership and talent development Ability to navigate ambiguity and drive clarity across complex global environments
#J-18808-Ljbffr
The Executive Director, Global Commercial Product Strategy for Lenacapavir for Prevention is responsible for shaping and leading the global commercial vision, strategy, and execution for one of Gilead’s most important long-acting HIV prevention portfolios. This leader will oversee global commercial launch of lenacapavir for HIV prevention and guide early commercial planning for future lenacapavir prevention assets in the pipeline. The role drives cross-functional alignment, regional partnership, market development, and launch excellence to enable sustained global growth. This position requires a strategic, collaborative leader with deep global commercial expertise, strong cross-functional leadership capabilities, and a passion for advancing HIV prevention worldwide. Responsibilities
Lead a cross-geography commercialization strategy and execution team to define and deliver the global commercial vision, long-range strategy, and integrated annual plans for the lenacapavir prevention portfolio. Serve as Commercialization Team Leader, enabling decision making across Medical Affairs, Clinical Development, Value & Access, Public Affairs, Government Affairs, Regulatory, Legal, and Insights partners. Lead the development of the Indication Strategic Plan (ISP) and Global Plan of Action (GPOA), ensuring clear linkage to regional and country HIV prevention plans. Lead, coach, and develop a high performing global team, fostering a culture of inclusion, accountability, collaboration, and innovation. Manage and shape external partnerships, agency relationships, and global marketing investments. Build strong and trusted partnerships with Gilead’s priority (G9) and emerging markets to ensure global strategies are actionable, scalable, and tailored to local needs. Collaborate closely with Value & Access to shape pricing, access, and reimbursement strategies across diverse healthcare, prevention, and policy environments. Support global guidelines, policy, and ecosystem shaping efforts to expand access to long-acting HIV prevention. Integrate global market intelligence, competitive insights, and customer needs into commercial, clinical, access, and evidence generation strategies. Identify and translate market, customer, and ecosystem insights into clear business opportunities, strategic priorities, and global commercial plans. Lead global launch readiness and market preparation for the ex-US rollout of lenacapavir for Prevention, ensuring coordinated preparation across regions. Oversee early commercial planning and readiness activities for future lenacapavir prevention assets as they advance through development. Drive global brand positioning, messaging, and multichannel campaign development to ensure clear differentiation and strong early market establishment. Provide commercial leadership into clinical development, lifecycle planning, evidence generation, and publication strategy to support future label, payer, and customer needs. Contribute to long-range planning, scenario planning, asset valuation, and enterprise strategy discussions. Develop executive level materials for Earnings Calls, LE guidance, long-range plan (LRP), governance forums, and strategic reviews. Represent Global Commercial Strategy in enterprise initiatives related to HIV, prevention, long-acting platforms, and access expansion. Qualifications
Required: 15+ years of biopharmaceutical commercial experience, including extensive global or regional strategy leadership. Required: Proven experience leading cross functional teams and influencing senior executive levels. Required: Experience working within or across multiple key markets. Required: Demonstrated success in global launch planning, market development, or brand strategy for specialty or prevention focused therapeutics. Required: Strong strategic thinking, analytical skills, and ability to translate insights into actionable strategies. Required: Excellent leadership, communication, and stakeholder management capabilities. Preferred: HIV, infectious disease, or prevention ecosystem experience. Preferred: Consumer/Direct to Consumer experience. Preferred: Prior responsibility for evidence strategy, lifecycle planning, or shaping policy/market access environments. Skills
Strategic agility and enterprise mindset Cross functional influence and decision leadership Customer, market, and policy insight orientation Inclusive people leadership and talent development Ability to navigate ambiguity and drive clarity across complex global environments
#J-18808-Ljbffr